Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Arthritis, Juvenile Chronic

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Arthritis, Juvenile Chronic in 1 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hamilton, J1
Balint, P1
Field, M1
Sturrock, RD1

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Arthritis, Juvenile Chronic

ArticleYear
A concealed cause of recurrent renal failure in a patient with juvenile chronic arthritis.
    Annals of the rheumatic diseases, 1999, Volume: 58, Issue:7

    Topics: Adult; Amphetamines; Arthritis, Juvenile; Hallucinogens; Humans; Kidney Failure, Chronic; Male; N-Me

1999